
EG110A is an investigational DNA medicine under development for neurogenic detrusor overactivity with urinary incontinence.
Bilal Chughtai, MD, an associate professor of Urology at Weill Cornell Medical College, discusses the safety of saw palmetto extract for patients with benign prostatic hyperplasia and lower urinary tract symptoms. Chughtai was part of an international panel of leading urologists from North America and Europe who published the

